GAM Holding’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-66,487
Closed -$11.5M 1193
2015
Q1
$11.5M Sell
66,487
-2,293
-3% -$337K 0.17% 151
2014
Q4
$7.91M Buy
68,780
+32,780
+91% +$3.97M 0.12% 206
2014
Q3
$5.63M Buy
36,000
+16,500
+85% +$2.39M 0.08% 270
2014
Q2
$2.4M Buy
19,500
+7,000
+56% +$774K 0.04% 454
2014
Q1
$1.29M Buy
12,500
+1,000
+9% +$102K 0.02% 626
2013
Q4
$1.03M Buy
11,500
+5,500
+92% +$439K 0.02% 591
2013
Q3
$401K Buy
6,000
+3,000
+100% +$207K 0.01% 841
2013
Q2
$198K Buy
+3,000
New +$172K ﹤0.01% 758

Other funds holding SLXP

GAM Holding's SLXP Position: Q2 2015 in Review

GAM Holding sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 66,487 shares — an estimated $11.5M sold.

GAM Holding first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $11.5M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • GAM Holding reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • GAM Holding sold 66,487 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $11.5M.
  • GAM Holding first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • GAM Holding's SALIX PHARMACEUTICALS LTD DEL position peaked at $11.5M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on GAM Holding's 13F filing for Q2 2015, filed 27 Jul 2015.